Rancho Santa Margarita, CA, United States of America

Hemant A Patel

This inventor holds 16 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Botulinum Neurotoxin Research. Top assignees: Allergan, Inc., Abbvie Inc.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hemant A Patel. Retrieved from https://idiyas.com/inventor/hemant-a-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 135(Granted Patents)

Company Filing History:

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Clostridium Botulinum

Neurotoxin Variants

Botulinum Toxin

Extraction Process

Biotechnology

Pharmaceuticals

Biologics

Toxin Characterization

Serotype A

Neurotoxin Production

Protein Engineering

Enzyme Activity

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502420 - Clostridium botulinum Serotype A Neurotoxin (BoNT/A) Sequence Variants (2025-12-23),

2. 12241098 - Process and system for obtaining botulinum neurotoxin (2025-03-04),

3. 11530400 - Process and system for obtaining botulinum neurotoxin (2022-12-20),

4. 11525130 - Process and system for obtaining botulinum neurotoxin (2022-12-13),

5. 11518986 - Process and system for obtaining botulinum neurotoxin (2022-12-06),

6. 11326155 - Process and system for obtaining botulinum neurotoxin (2022-05-10),

7. 11203748 - Process and system for obtaining botulinum neurotoxin (2021-12-21),

8. 11124786 - Process and system for obtaining botulinum neurotoxin (2021-09-21),

9. 10465178 - Process and system for obtaining botulinum neurotoxin (2019-11-05),

10. 9719076 - Process and system for obtaining botulinum neurotoxin (2017-08-01),

11. 9206409 - Process and system for obtaining botulinum neurotoxin (2015-12-08),

12. 8932827 - Process and system for obtaining botulinum neurotoxin (2015-01-13),

13. 8927229 - Process and system for obtaining botulinum neurotoxin (2015-01-06),

14. 8357541 - Process and system for obtaining botulinum neurotoxin (2013-01-22),

15. 8324349 - Process for obtaining botulinum neurotoxin (2012-12-04),

Title: Hemant A Patel: Pioneering Innovator in Botulinum Neurotoxin Processes

Introduction:

Hailing from Rancho Santa Margarita, CA, Hemant A Patel is a distinguished inventor with a remarkable portfolio of 14 patents in various fields. His expertise lies in the development of cutting-edge processes and systems for obtaining botulinum neurotoxin for a range of applications.

Latest Patents:

Among his latest patents, Patel has revolutionized the field with his process and system for obtaining botulinum neurotoxin. These rapid, animal protein-free, chromatographic processes and systems are designed to deliver high potency and high yield botulinum neurotoxin suitable for research, therapeutic, and cosmetic purposes.

Career Highlights:

Patel is associated with Allergan, Inc., a renowned company in the pharmaceutical and biotechnology industry. His contributions have significantly impacted the company's innovative strides in the field of botulinum neurotoxin research and production.

Collaborations:

In his professional journey, Patel has collaborated closely with esteemed colleagues such as Jennifer L Ton and Ronald Charles Bates. Together, they have synergized their expertise to drive forward advancements in the realm of neurotoxin research and development.

Conclusion:

In conclusion, Hemant A Patel emerges as a trailblazing inventor who has reshaped the landscape of botulinum neurotoxin processes. His dedication to scientific excellence and inventive spirit continue to propel breakthroughs in the field, cementing his legacy as a driving force in innovation.

Profile summary based on public USPTO records.